122 related articles for article (PubMed ID: 37502854)
1. Selective Blood Cell Hitchhiking in Whole Blood with Ionic Liquid-Coated PLGA Nanoparticles to Redirect Biodistribution After Intravenous Injection.
Hamadani CM; Dasanayake GS; Chism CM; Gorniak ME; Monroe WG; Merrell A; Pride MC; Heintz R; Wong K; Hossain M; Taylor G; Edgecomb SX; Jones D; Dhar J; Banka A; Singh G; Vashisth P; Randall J; Darlington DS; Everett J; Jarrett E; Werfel TA; Eniola-Adefeso O; Tanner EEL
Res Sq; 2023 Jul; ():. PubMed ID: 37502854
[TBL] [Abstract][Full Text] [Related]
2. Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery.
Hamadani CM; Dasanayake GS; Gorniak ME; Pride MC; Monroe W; Chism CM; Heintz R; Jarrett E; Singh G; Edgecomb SX; Tanner EEL
Nat Protoc; 2023 Aug; 18(8):2509-2557. PubMed ID: 37468651
[TBL] [Abstract][Full Text] [Related]
3. Protein-avoidant ionic liquid (PAIL)-coated nanoparticles to increase bloodstream circulation and drive biodistribution.
Hamadani CM; Goetz MJ; Mitragotri S; Tanner EEL
Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33239302
[TBL] [Abstract][Full Text] [Related]
4. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Dasanayake GS; Darlington DS; Singh G; Pride MC; Monroe WG; Taylor GR; Hunter AN; Roman G; Paris JJ; Tanner EEL
Adv Sci (Weinh); 2024 Jun; 11(23):e2305484. PubMed ID: 38572510
[TBL] [Abstract][Full Text] [Related]
5. Improved nanoformulation and bio-functionalization of linear-dendritic block copolymers with biocompatible ionic liquids.
Hamadani CM; Chandrasiri I; Yaddehige ML; Dasanayake GS; Owolabi I; Flynt A; Hossain M; Liberman L; Lodge TP; Werfel TA; Watkins DL; Tanner EEL
Nanoscale; 2022 Apr; 14(16):6021-6036. PubMed ID: 35362493
[TBL] [Abstract][Full Text] [Related]
6. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Pride MC; Hunter AN; Singh G; Roman G; Paris JJ; Tanner EEL
Res Sq; 2023 Feb; ():. PubMed ID: 36824802
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties.
Zheng J; Lu C; Ding Y; Zhang J; Tan F; Liu J; Yang G; Wang Y; Li Z; Yang M; Yang Y; Gong W; Gao C
Int J Pharm; 2022 May; 619():121719. PubMed ID: 35390488
[TBL] [Abstract][Full Text] [Related]
8. Good's Buffer Based Highly Biocompatible Ionic Liquid Modified PLGA Nanoparticles for the Selective Uptake in Cancer Cells.
Singh G; Dasanayake GS; Chism CM; Vashisth P; Kaur A; Misra SK; Sharp JS; Tanner EEL
Mater Chem Front; 2023 Dec; 7(24):6213-6228. PubMed ID: 38204762
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
10. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
Brenner JS; Mitragotri S; Muzykantov VR
Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
[TBL] [Abstract][Full Text] [Related]
11. Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles.
Yadav KS; Chuttani K; Mishra AK; Sawant KK
PDA J Pharm Sci Technol; 2011; 65(2):131-9. PubMed ID: 21502074
[TBL] [Abstract][Full Text] [Related]
12. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
13. A numerical study on drug delivery
Nikfar M; Razizadeh M; Paul R; Muzykantov V; Liu Y
Nanoscale; 2021 Oct; 13(41):17359-17372. PubMed ID: 34590654
[TBL] [Abstract][Full Text] [Related]
14. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.
Anselmo AC; Gupta V; Zern BJ; Pan D; Zakrewsky M; Muzykantov V; Mitragotri S
ACS Nano; 2013 Dec; 7(12):11129-37. PubMed ID: 24182189
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
[TBL] [Abstract][Full Text] [Related]
16. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
[TBL] [Abstract][Full Text] [Related]
17. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption.
Lenders V; Escudero R; Koutsoumpou X; Armengol Álvarez L; Rozenski J; Soenen SJ; Zhao Z; Mitragotri S; Baatsen P; Allegaert K; Toelen J; Manshian BB
J Nanobiotechnology; 2022 Jul; 20(1):333. PubMed ID: 35842697
[TBL] [Abstract][Full Text] [Related]
18. Engineered nanomedicine for myeloma and bone microenvironment targeting.
Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
20. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.
Hu F; Zhang R; Guo W; Yan T; He X; Hu F; Ren F; Ma X; Lei J; Zheng W
Mol Pharm; 2021 Jun; 18(6):2161-2173. PubMed ID: 32515968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
